|
Cardiovascular Pharmacology
Citations 101-110 of 640 total displayed.
|
Past content
(since Jan 1999):
|
- Brief Reviews
Role of Endothelin-1 in Clinical Hypertension. 20 Years On
- Neeraj Dhaun, Jane Goddard, Donald E. Kohan, David M. Pollock, Ernesto L. Schiffrin, and David J. Webb
Hypertension published August 4, 2008, doi:10.1161/HYPERTENSIONAHA.108.117366
[Abstract]
- Letters to the Editor
It Is the Plasma Renin Activity Level That Counts, not Stoichiometry
- Jean E. Sealey and John H. Laragh
Hypertension 2008;52:e20; published online before print as doi:10.1161/HYPERTENSIONAHA.108.116319
[Full text]
- Letters to the Editor
Response to It Is the Plasma Renin Activity Level That Counts, not Stoichiometry
- Juerg Nussberger, Alice Stanton, Naomi D.L. Fisher, Norman K. Hollenberg, and A.H. Jan Danser
Hypertension 2008;52:e21; published online before print as doi:10.1161/HYPERTENSIONAHA.108.116483
[Full text]
- Editorial Commentaries
Antihypertensive Therapy in Children: Implications for Future Studies
- Alan R. Sinaiko
Hypertension 2008;52:201-202; published online before print as doi:10.1161/HYPERTENSIONAHA.108.112433
[Full text]
- Original Articles
Efficacy and Safety of the Angiotensin Receptor Blocker Valsartan in Children With Hypertension Aged 1 to 5 Years
- Joseph T. Flynn, Kevin E.C. Meyers, Jose Pacheco Neto, Rejane de Paula Meneses, Aleksandra Zurowska, Arvind Bagga, Lionel Mattheyse, Victor Shi, Jitendra Gupte, Susan Solar-Yohay, Guangyang Han for the Pediatric Valsartan Study Group
Hypertension 2008;52:222-228; published online before print as doi:10.1161/HYPERTENSIONAHA.108.111054
[Abstract]
[Full text]
- Original Articles
Cerebral Hemodynamics During Treatment With Sodium Nitroprusside Versus Labetalol in Malignant Hypertension
- Rogier V. Immink, Bert-Jan H. van den Born, Gert A. van Montfrans, Yu-Sok Kim, Markus W. Hollmann, and Johannes J. van Lieshout
Hypertension 2008;52:236-240; published online before print as doi:10.1161/HYPERTENSIONAHA.108.110395
[Abstract]
[Full text]
- Original Articles
Deletion of Transient Receptor Potential Vanilloid Type 1 Receptors Exaggerates Renal Damage in Deoxycorticosterone Acetate-Salt Hypertension
- Youping Wang, Dagmar Babánková, Jie Huang, Greg M. Swain, and Donna H. Wang
Hypertension 2008;52:264-270; published online before print as doi:10.1161/HYPERTENSIONAHA.108.110197
[Abstract]
[Full text]
- Original Articles
History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure
- Bertram Pitt, Ali Ahmed, Thomas E. Love, Henry Krum, Jose Nicolau, José S. Cardoso, Alexander Parkhomenko, Michael Aschermann, Ramon Corbalán, Henry Solomon, Harry Shi, and Faiez Zannad
Hypertension 2008;52:271-278; published online before print as doi:10.1161/HYPERTENSIONAHA.107.109314
[Abstract]
[Full text]
- Original Articles
Serotonin 5-HT2B Receptor Blockade Prevents Reactive Oxygen Species–Induced Cardiac Hypertrophy in Mice
- Laurent Monassier, Marc-André Laplante, Fabrice Jaffré, Pascal Bousquet, Luc Maroteaux, and Jacques de Champlain
Hypertension 2008;52:301-307; published online before print as doi:10.1161/HYPERTENSIONAHA.107.105551
[Abstract]
[Full text]
- Letters to the Editor
Response to It Is the Plasma Renin Activity Level That Counts, not Stoichiometry
- Juerg Nussberger, Alice Stanton, Naomi D.L. Fisher, Norman K. Hollenberg, and A. H. Jan Danser
Hypertension published July 7, 2008, doi:10.1161/HYPERTENSIONAHA.108.116483
[Abstract]
|
|
